Given that TIPE3 has an important and common regulatory role in the initiation and progression of multiple cancers, an effective broad-spectrum anti-tumor therapeutic strategy targeting TIPE3 using small-molecule inhibitors is revealed. This evidence concerns the gene TIPE3 and neoplasm.